|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Costs and expenses: | |||||
| Cost of services, exclusive of depreciation and amortization | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Total costs and expenses | |||||
| Other operating income | |||||
| Income from continuing operations before other income and expense | |||||
| Other income and expense: | |||||
| Loss on early retirement of debt | |||||
| Gain on sale of businesses | |||||
| Interest income | |||||
| Equity in earnings of unconsolidated subsidiaries | |||||
| Interest expense | |||||
| Income from continuing operations before income taxes | |||||
| Income tax expense from continuing operations | |||||
| Income from continuing operations, net of tax | |||||
| Discontinued operations: | |||||
| Income from discontinued business | |||||
| Income tax expense from discontinued business | |||||
| Income from discontinued operations, net of tax | |||||
| Net income | |||||
| Less: Net income attributable to non-controlling interests | |||||
| Net income attributable to Select Medical Holdings Corporation | |||||
| Net income attributable to Select Medical Holdings Corporation’s common stockholders: | |||||
| Income from continuing operations, net of tax | |||||
| Income from discontinued operations, net of tax | |||||
| Earnings (loss) per common share | |||||
| Continuing operations - basic (in dollars per share) | |||||
| Continuing operations - diluted (in dollars per share) | |||||
| Discontinued operations - basic (in dollars per share) | |||||
| Discontinued operations - diluted (in dollars per share) | |||||
| Total earnings per common share - basic (in dollars per share) | |||||
| Total earnings per common share - diluted (in dollars per share) |
Loading...